1. Home
  2. RMTI

as of 12-31-2025 3:54pm EST

$0.83
+$0.01
+1.75%
Stocks Health Care Biotechnology: Pharmaceutical Preparations Nasdaq

Rockwell Medical Inc is a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers. It is a supplier of liquid bicarbonate concentrates, and acid and dry bicarbonate concentrates for dialysis patients in the United States. The company's products include CitraPure citric acid concentrate, RenalPure liquid acid concentrate, and SteriLyte bicarbonate concentrate among others.

Founded: 1994 Country:
United States
United States
Employees: N/A City: WIXOM
Market Cap: 35.1M IPO Year: 1998
Target Price: $2.50 AVG Volume (30 days): 235.6K
Analyst Decision: Strong Buy Number of Analysts: 1
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -0.17 EPS Growth: N/A
52 Week Low/High: $0.78 - $2.41 Next Earning Date: 11-12-2025
Revenue: $75,577,000 Revenue Growth: -23.60%
Revenue Growth (this year): -32.2% Revenue Growth (next year): 8.12%

AI-Powered RMTI Daily Prediction

Machine learning model trained on 25+ technical indicators

Updated a day ago

AI Recommendation

hold
Model Accuracy: 76.03%
76.03%
Confidence

Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.

Stock Insider Trading Activity of Rockwell Medical Inc. (RMTI)

Sell
RMTI Nov 18, 2025

Avg Cost/Share

$0.87

Shares

5,079

Total Value

$4,418.73

Owned After

140,372

SEC Form 4

Share on Social Networks: